PRTC
Income statement / Annual
Last year (2023), PureTech Health plc's total revenue was $3.33 M,
an increase of 59.33% from the previous year.
In 2023, PureTech Health plc's net income was -$65.70 M.
See PureTech Health plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$3.33 M |
$2.09 M |
$9.98 M |
$8.34 M |
$8.69 M |
$16.37 M |
$650,000.00 |
$4.43 M |
$11.74 M |
$2.01 M |
| Cost of Revenue |
$4.93 M
|
$152.43 M
|
$110.47 M
|
$0.00
|
$85.85 M
|
$77.40 M
|
$71.04 M
|
$1.57 M
|
$740,000.00
|
$0.00
|
| Gross Profit |
-$1.60 M
|
-$150.34 M
|
-$100.49 M
|
$8.34 M
|
-$77.16 M
|
-$61.03 M
|
-$70.39 M
|
$2.86 M
|
$11.00 M
|
$2.01 M
|
| Gross Profit Ratio |
-0.48
|
-71.93
|
-10.07
|
1
|
-8.88
|
-3.73
|
-108.28
|
0.65
|
0.94
|
1
|
| Research and Development Expenses |
$96.24 M
|
$116.11 M
|
$81.52 M
|
$61.19 M
|
$65.17 M
|
$57.29 M
|
$71.67 M
|
$41.21 M
|
$13.41 M
|
$2.84 M
|
| General & Administrative Expenses |
$25.18 M
|
$35.67 M
|
$30.76 M
|
$26.50 M
|
$34.89 M
|
$24.43 M
|
$46.28 M
|
$37.16 M
|
$18.38 M
|
$7.17 M
|
| Selling & Marketing Expenses |
$23.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$48.36 M
|
$35.67 M
|
$30.76 M
|
$26.50 M
|
$34.89 M
|
$24.43 M
|
$46.28 M
|
$37.16 M
|
$18.38 M
|
$7.17 M
|
| Other Expenses |
$0.00
|
$48.12 M
|
$47.98 M
|
$40.19 M
|
$44.03 M
|
-$278,000.00
|
$14,000.00
|
$46,000.00
|
$448,000.00
|
$0.00
|
| Operating Expenses |
$146.95 M
|
$199.90 M
|
$160.26 M
|
$127.87 M
|
$144.09 M
|
$120.39 M
|
$116.07 M
|
$78.36 M
|
$55.38 M
|
$19.46 M
|
| Cost And Expenses |
$149.53 M
|
$199.90 M
|
$160.26 M
|
$127.87 M
|
$144.09 M
|
$120.39 M
|
$116.07 M
|
$78.36 M
|
$55.38 M
|
$19.46 M
|
| Interest Income |
$16.01 M
|
$5.80 M
|
$214,000.00
|
$1.18 M
|
$4.36 M
|
$3.36 M
|
$1.75 M
|
$1.29 M
|
$262,000.00
|
$46,000.00
|
| Interest Expense |
$13.49 M
|
$3.95 M
|
$4.71 M
|
$2.95 M
|
$2.64 M
|
$392,000.00
|
$553,000.00
|
$801,000.00
|
$835,000.00
|
$2.59 M
|
| Depreciation & Amortization |
$4.93 M
|
$8.89 M
|
$7.24 M
|
$6.66 M
|
$6.67 M
|
$2.78 M
|
$2.10 M
|
$1.57 M
|
$740,000.00
|
$455,000.00
|
| EBITDA |
-$11.63 M |
-$52.19 M |
-$46.95 M |
$62.69 M |
$458.45 M |
-$65.27 M |
-$40.79 M |
-$74.80 M |
-$51.23 M |
-$73.24 M |
| EBITDA Ratio |
-3.49
|
-96.99
|
-21.53
|
-17.35
|
-10.92
|
-7.57
|
-213.34
|
-17.47
|
-3.87
|
-8.42
|
| Operating Income Ratio |
-43.9
|
-94.64
|
-15.06
|
-14.33
|
-15.58
|
-6.35
|
-177.57
|
-16.68
|
-3.72
|
-8.67
|
| Total Other Income/Expenses Net |
$110.10 M
|
$105.02 M
|
$91.33 M
|
$138.50 M
|
$613.87 M
|
$35.58 M
|
$44.71 M
|
-$9.25 M
|
-$12.68 M
|
-$58.78 M
|
| Income Before Tax |
-$36.10 M
|
-$92.78 M
|
-$58.95 M
|
$18.97 M
|
$478.47 M
|
-$68.44 M
|
-$70.71 M
|
-$83.18 M
|
-$56.32 M
|
-$76.22 M
|
| Income Before Tax Ratio |
-10.84
|
-44.39
|
-5.91
|
2.27
|
55.07
|
-4.18
|
-108.79
|
-18.77
|
-4.8
|
-37.88
|
| Income Tax Expense |
$30.53 M
|
-$55.72 M
|
$3.76 M
|
$14.40 M
|
$112.41 M
|
$2.22 M
|
-$14,000.00
|
-$1.57 M
|
$1.92 M
|
-$278,000.00
|
| Net Income |
-$65.70 M
|
-$37.06 M
|
-$62.71 M
|
$4.57 M
|
$421.14 M
|
-$43.65 M
|
$30.87 M
|
-$48.79 M
|
-$39.39 M
|
-$41.64 M
|
| Net Income Ratio |
-19.73
|
-17.73
|
-6.28
|
0.55
|
48.47
|
-2.67
|
47.49
|
-11.01
|
-3.36
|
-20.7
|
| EPS |
-2.38 |
-0.18 |
-0.21 |
0.021 |
1.49 |
-0.16 |
0.11 |
-0.21 |
-0.21 |
-0.51 |
| EPS Diluted |
-0.24 |
-0.18 |
-0.21 |
0.02 |
1.44 |
-0.16 |
0.11 |
-0.21 |
-0.21 |
-0.51 |
| Weighted Average Shares Out |
$27.63 M
|
$279.75 M
|
$286.59 M
|
$299.26 M
|
$292.46 M
|
$272.84 M
|
$240.65 M
|
$229.51 M
|
$185.28 M
|
$81.65 M
|
| Weighted Average Shares Out Diluted |
$276.30 M
|
$284.76 M
|
$286.59 M
|
$292.86 M
|
$291.78 M
|
$273.85 M
|
$238.92 M
|
$229.51 M
|
$185.28 M
|
$82.45 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
